Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey
Links shared publicly online about this topic.
- 519total visits
Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe psoriasis, the highest proportion of surveyed dermatologists and managed care organizations' (MCOs) pharmacy directors indicate that Abbott/Eisai's Humira and Amgen/Pfizer/Stiefel/Takeda's Enbrel have the best overall clinical profile when compared to other currently available agents.
View full resource at news-medical.net
Tags: Psoriasis, Crohn's Disease Medication, Rheumatoid Arthritis Medication, Healthcare, Pharma, Enbrel, Humira
Most Recently Shared on February 9, 2011 at 3:22 pm By:
Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey: Deci... http://bit.ly/ieEoBf
For the Treatment of Moderate to Severe Psoriasis, the Highest Proportion of Surveyed Dermatologists and MCOs Indicate That Humira and Enbrel Have the Best Overall Clinical Profile When Compared to Other Currently Available Agents | Business Wire
businesswire.com — “Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatme” View full resource at businesswire.com
Most Recently Shared on February 7, 2011 at 9:16 pm By:
For the Treatment of Moderate to Severe Psoriasis, the Highest Proportion of Surveyed Dermatologists and MCOs In... http://bit.ly/fgMTjb
Advertisement
